Dariclox

Dariclox

Dariclox Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

WARNINGS: Milk taken from animals during treatment and for 48 hours (4 milkings) after the last treatment must not be used for food. Treated animals must not be slaughtered for food purposes within 10 days after the last treatment.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

INDICATIONS: Dariclox is indicated in the treatment of bovine mastitis in lactating cows due to Streptococcus agalactiae and nonpenicillinase-producing Staphylococcus aureus.

Clinical experience indicates that antibiotic efficacy in the treatment of mastitis in lactating cows is directly related to the duration of infection. Therefore, treatment should be instituted as early as possible after detection.

History

There is currently no drug history available for this drug.

Other Information

DESCRIPTION: Dariclox (sodium cloxacillin) is a stable, nonirritating suspension of sodium cloxacillin containing the equivalent of 200 mg of cloxacillin in saturated vegetable oils per disposable syringe. Dariclox is manufactured by a nonsterilizing process.

Cloxacillin is a semisynthetic penicillin derived from the penicillin nucleus, 6-amino-penicillanic acid. Sodium cloxacillin is the monohydrate sodium salt of 5-methyl-3-(o-chlorophenyl)-4-isoxazolyl penicillin.

Dariclox Manufacturers


  • Merck Sharp & Dohme Corp.
    Dariclox (Cloxacillin Sodium) Suspension [Merck Sharp & Dohme Corp.]

Login To Your Free Account